As novel cancer treatments continually emerge, it is essential to collect data on patients’ quality of life along with how the treatment is working to extend survival. This is particularly true in young people with cancer who may be more prone to health complications later, according to a nationwide study involving children and teenagers led by AnnaLynn Williams, Ph.D., at the Wilmot Cancer Institute.
Measuring ‘quality of life’ is an important trend in cancer care
